Ajax-Loading

Eli Lilly and Company - Working Capital Turnover

Eli Lilly and Company's Fiscal Year is From January To December.

The item "Working-Capital-Turnover" stands at 4.92 as of 09/30/2025, the lowest value at least since 06/30/2022, the period currently displayed.

As of the end of Eli Lilly and Company's third quarter, the item "Working Capital Turnover" stands at 4.92. This represents a decrease of -23.50 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -55.32 percent compared to the value the year prior.
The 1 year change in percent is -55.32.
The 3 year change in percent is -56.01.

The Serie's long term average value is 11.65. It's latest available value, on 09/30/2025, is 57.77 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is +0.0%.
The Serie's change in percent from it's maximum value, on 12/31/2023, to it's latest available value, on 09/30/2025, is -76.00%.

Working Capital Turnover for Related Companies:

LogoNameMarket Cap (USD)
LogoJohnson & Johnson - Working Capital Turnover486,508,953,600.00
LogoAbbVie Inc - Working Capital Turnover399,570,305,024.00
LogoRoche Holding AG - Working Capital Turnover317,433,206,677.55
LogoAstraZeneca PLC - Working Capital Turnover280,205,508,085.11
LogoNovartis AG - Working Capital Turnover255,096,620,580.91